These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 21824834)
21. Asymmetric STN DBS for FOG in Parkinson's disease: A pilot trial. Meoni S; Debȗ B; Pelissier P; Scelzo E; Castrioto A; Seigneuret E; Chabardes S; Fraix V; Moro E Parkinsonism Relat Disord; 2019 Jun; 63():94-99. PubMed ID: 30826266 [TBL] [Abstract][Full Text] [Related]
22. 80 Hz versus 130 Hz subthalamic nucleus deep brain stimulation: effects on involuntary movements. Merola A; Zibetti M; Artusi CA; Rizzi L; Angrisano S; Lanotte M; Lopiano L; Rizzone MG Parkinsonism Relat Disord; 2013 Apr; 19(4):453-6. PubMed ID: 23395217 [TBL] [Abstract][Full Text] [Related]
23. Stratifying Parkinson's Patients With STN-DBS Into High-Frequency or 60 Hz-Frequency Modulation Using a Computational Model. Khojandi A; Shylo O; Mannini L; Kopell BH; Ramdhani RA Neuromodulation; 2017 Jul; 20(5):450-455. PubMed ID: 28480524 [TBL] [Abstract][Full Text] [Related]
24. Amantadine improves gait in PD patients with STN stimulation. Chan HF; Kukkle PL; Merello M; Lim SY; Poon YY; Moro E Parkinsonism Relat Disord; 2013 Mar; 19(3):316-9. PubMed ID: 23218842 [TBL] [Abstract][Full Text] [Related]
25. Differential effects of deep brain stimulation target on motor subtypes in Parkinson's disease. Katz M; Luciano MS; Carlson K; Luo P; Marks WJ; Larson PS; Starr PA; Follett KA; Weaver FM; Stern MB; Reda DJ; Ostrem JL; Ann Neurol; 2015 Apr; 77(4):710-9. PubMed ID: 25627340 [TBL] [Abstract][Full Text] [Related]
27. Low-frequency subthalamic nucleus deep brain stimulation for axial symptoms in advanced Parkinson's disease. Sidiropoulos C; Walsh R; Meaney C; Poon YY; Fallis M; Moro E J Neurol; 2013 Sep; 260(9):2306-11. PubMed ID: 23749331 [TBL] [Abstract][Full Text] [Related]
28. Depression may negatively affect the change in freezing of gait following subthalamic nucleus stimulation in Parkinson's disease. Kim R; Kim HJ; Kim A; Kim Y; Kim AR; Shin CW; Paek SH; Jeon B Parkinsonism Relat Disord; 2017 Nov; 44():133-136. PubMed ID: 28830666 [TBL] [Abstract][Full Text] [Related]
29. Entraining Stepping Movements of Parkinson's Patients to Alternating Subthalamic Nucleus Deep Brain Stimulation. Fischer P; He S; de Roquemaurel A; Akram H; Foltynie T; Limousin P; Zrinzo L; Hyam J; Cagnan H; Brown P; Tan H J Neurosci; 2020 Nov; 40(46):8964-8972. PubMed ID: 33087473 [TBL] [Abstract][Full Text] [Related]
30. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients. Yoshida F; Miyagi Y; Kishimoto J; Morioka T; Murakami N; Hashiguchi K; Samura K; Sakae N; Yamasaki R; Kawaguchi M; Sasaki T Stereotact Funct Neurosurg; 2009; 87(1):45-9. PubMed ID: 19174620 [TBL] [Abstract][Full Text] [Related]
31. Only physical aspects of quality of life are significantly improved by bilateral subthalamic stimulation in Parkinson's disease. Drapier S; Raoul S; Drapier D; Leray E; Lallement F; Rivier I; Sauleau P; Lajat Y; Edan G; Vérin M J Neurol; 2005 May; 252(5):583-8. PubMed ID: 15778909 [TBL] [Abstract][Full Text] [Related]
32. Comparison of Subthalamic Nucleus vs. Globus Pallidus Interna Deep Brain Stimulation in Terms of Gait and Balance; A Two Year Follow-Up Study. Celiker O; Demir G; Kocaoglu M; Altug F; Acar F Turk Neurosurg; 2019; 29(3):355-361. PubMed ID: 30984985 [TBL] [Abstract][Full Text] [Related]
33. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946 [TBL] [Abstract][Full Text] [Related]
35. Subthalamic Nucleus Deep Brain Stimulation for Parkinson Disease in Hong Kong: A Prospective Territory-Wide 2-Year Follow-Up Study. Chan DT; Zhu CX; Lau CK; Poon TL; Cheung FC; Lee M; Taw B; Hung KN; Choi P; AuYeung M; Chan G; Cheung YF; Chan AY; Yeung JH; Mok VC; Poon WS; World Neurosurg; 2016 Sep; 93():229-36. PubMed ID: 27297243 [TBL] [Abstract][Full Text] [Related]
36. Effects of deep brain stimulation on balance and gait in patients with Parkinson's disease: A systematic neurophysiological review. Collomb-Clerc A; Welter ML Neurophysiol Clin; 2015 Nov; 45(4-5):371-88. PubMed ID: 26319759 [TBL] [Abstract][Full Text] [Related]
37. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation. Castrioto A; Lozano AM; Poon YY; Lang AE; Fallis M; Moro E Arch Neurol; 2011 Dec; 68(12):1550-6. PubMed ID: 21825213 [TBL] [Abstract][Full Text] [Related]
38. Acute response of non-motor symptoms to subthalamic deep brain stimulation in Parkinson's disease. Fabbri M; Coelho M; Guedes LC; Rosa MM; Abreu D; Gonçalves N; Antonini A; Ferreira JJ Parkinsonism Relat Disord; 2017 Aug; 41():113-117. PubMed ID: 28528805 [TBL] [Abstract][Full Text] [Related]
39. Unilateral deep brain stimulation of the subthalamic nucleus for Parkinson disease. Slowinski JL; Putzke JD; Uitti RJ; Lucas JA; Turk MF; Kall BA; Wharen RE J Neurosurg; 2007 Apr; 106(4):626-32. PubMed ID: 17432714 [TBL] [Abstract][Full Text] [Related]
40. Frequency-dependent effects of subthalamic deep brain stimulation on motor symptoms in Parkinson's disease: a meta-analysis of controlled trials. Su D; Chen H; Hu W; Liu Y; Wang Z; Wang X; Liu G; Ma H; Zhou J; Feng T Sci Rep; 2018 Sep; 8(1):14456. PubMed ID: 30262859 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]